Cancer Therapy-induced Thrombocytopenia

• CLINICAL_TRIALS research · 2026-04-14
  Clinical Trial Update: A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11 [Phase 3]

  Phase 3 clinical trial update showing recruitment for a study comparing Romiplostim N01 versus recombinant human interleukin-11 for cancer t…

• CLINICAL_TRIALS research · 2026-01-12
  Clinical Trial Update: A Study of Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients. [Phase 2]

  A Phase 2 clinical trial evaluating hetrombopag in combination with recombinant human thrombopoietin (rhTPO) for cancer therapy-induced thro…

• CLINICAL_TRIALS research · 2025-09-09
  Clinical Trial Update: Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT) [Phase 1]

  Phase 1 clinical trial update: Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for cancer therapy-induced thrombocytopenia is curre…